The drug has been in short supply since at least August, an issue that
Teva spokesperson Kelley Dougherty said the company continues to experience intermittent delays in Adderall production and is “producing and distributing ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.